Thu, April 6, 2023
Wed, April 5, 2023
Tue, April 4, 2023
Mon, April 3, 2023
Sat, April 1, 2023
Fri, March 31, 2023
Thu, March 30, 2023

Vikram Purohit Downgraded (ASND) to Hold and Decreased Target to $108 on, Apr 4th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-decreased-target-to-108-on-apr-4th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Vikram Purohit of Morgan Stanley, Downgraded "Ascendis Pharma A/S" (ASND) to Hold and Decreased Target from $151 to $108 on, Apr 4th, 2023.

Vikram has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 1 agrees with Vikram's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Downgraded from Buy to Hold on, Monday, April 3rd, 2023


These are the ratings of the 2 analyists that currently disagree with Vikram


  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $163 on, Tuesday, January 17th, 2023
  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $177 on, Tuesday, January 3rd, 2023

Publication Contributing Sources